Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A GAF domain-containing protein is defined by the presence of a GAF domain—a conserved protein module of approximately 150 amino acids, named for cGMP-specific phosphodiesterases, adenylyl cyclases, and FhlA[3][5][7][8]. These domains function as regulatory modules capable of binding small molecules (such as cyclic nucleotides), enabling allosteric modulation of protein activity. GAF domains are found in numerous proteins across bacteria, plants, and animals, especially in cyclic nucleotide phosphodiesterases (such as PDE2, PDE5, PDE6, PDE10, and PDE11 in mammals), where they mediate cyclic nucleotide-dependent regulation of enzymatic activity[4][5]. They are also present in sensory and signaling proteins such as phytochromes, adenylyl cyclases, and bacterial transcription factors[1][3][5]. Through ligand binding (for example cGMP or cAMP), GAF domains induce conformational rearrangements that regulate the activity of the host protein, impacting diverse biological processes including signal transduction, gene expression, sensory perception, and disease pathophysiology[2][4][5]. The GAF domain is evolutionarily related to the PAS domain, and both contribute to sensory and signaling functions in cells[5][6]. Drugs targeting GAF-domain containing phosphodiesterases—most notably PDE5 inhibitors—are established therapeutics for erectile dysfunction and pulmonary hypertension, while mutations in other GAF-domain proteins (such as PDE6B) are linked to inherited retinal diseases[6]. Given their central role in mediating responses to cyclic nucleotides, GAF domain-containing proteins are major regulators and therapeutic targets in physiology and disease[4][5].
Allosteric inhibition of phosphodiesterases (by blocking cGMP/cAMP binding and thus regulating enzyme activity) Modulation of cyclic nucleotide levels, leading to downstream effects in vascular, neural, and reproductive tissues[4][5]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GAF domain-containing protein.